- Home
- NPCE vs RENB Comparison
NPCE vs RENB Comparison
Compare NPCE & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- RENB
- Stock Information
- Founded
- NPCE 1997
- RENB 2011
- Country
- NPCE United States
- RENB United States
- Employees
- NPCE N/A
- RENB N/A
- Industry
- NPCE Medical Specialities
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- NPCE Health Care
- RENB Health Care
- Exchange
- NPCE Nasdaq
- RENB Nasdaq
- Market Cap
- NPCE 336.7M
- RENB 279.3M
- IPO Year
- NPCE 2021
- RENB N/A
- Fundamental
- Price
- NPCE $10.64
- RENB $1.68
- Analyst Decision
- NPCE Buy
- RENB
- Analyst Count
- NPCE 7
- RENB 0
- Target Price
- NPCE $15.29
- RENB N/A
- AVG Volume (30 Days)
- NPCE 67.6K
- RENB 1.0M
- Earning Date
- NPCE 11-12-2024
- RENB 02-12-2025
- Dividend Yield
- NPCE N/A
- RENB N/A
- EPS Growth
- NPCE N/A
- RENB N/A
- EPS
- NPCE N/A
- RENB N/A
- Revenue
- NPCE $76,452,000.00
- RENB N/A
- Revenue This Year
- NPCE $23.46
- RENB N/A
- Revenue Next Year
- NPCE $15.49
- RENB N/A
- P/E Ratio
- NPCE N/A
- RENB N/A
- Revenue Growth
- NPCE 27.00
- RENB N/A
- 52 Week Low
- NPCE $5.45
- RENB $0.40
- 52 Week High
- NPCE $18.15
- RENB $5.25
- Technical
- Relative Strength Index (RSI)
- NPCE 54.53
- RENB 66.39
- Support Level
- NPCE $10.00
- RENB $1.50
- Resistance Level
- NPCE $12.41
- RENB $2.00
- Average True Range (ATR)
- NPCE 1.04
- RENB 0.33
- MACD
- NPCE -0.14
- RENB 0.03
- Stochastic Oscillator
- NPCE 28.67
- RENB 71.03
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.